A collection of new and previously published articles on coronavirus research and treatment. To submit a manuscript please follow the link below.
Yashvardhini, N., Jha, D., Kumar, A., Sayrav, K., & Gaurav, M. (2021).
Genetic variations in the Orf7a protein of SARS-CoV-2 and its possible role in vaccine development.
Biomedical Research and Therapy,
8(8), 4497-4504.
https://doi.org/10.15419/bmrat.v8i8.688
Zafar, N., Aslam, M., Ali, A., Khatoon, A., Nazir, A., Tanveer, Q., Bilal, M., Kanwar, R., Qadeer, A., Sikandar, M., & Zafar, A. (2020).
Probiotics: Helpful for the prevention of COVID-19?.
Biomedical Research and Therapy,
7(11), 4086-4099.
https://doi.org/10.15419/bmrat.v7i11.646
Mehreen, U., Ali, A., Khatoon, A., Zafar, N., Tanveer, Q., & Basit, I. (2020).
Kidney damage by COVID-19 and rationale for extracorporeal therapies.
Biomedical Research and Therapy,
7(10), 4071-4074. https://doi.org/10.15419/bmrat.v7i10.644
Taghadosi, M., Ajorpaz, N., & Aghajani, M. (2020).
Clinical decision-making approaches by health caregivers of patients with COVID-19.
Biomedical Research and Therapy,
7(10), 4056-4057. https://doi.org/10.15419/bmrat.v7i10.641
Bajelan, B., Salehifar, P., Karami, A., Salimi, M., Janbakhsh, A., Maleki, Z., Farhadi, K., Karimi, B., Tahmasebi, M., Ghasemi, A., Gholami, A., Sayad, B., & Payandeh, M. (2020).
Convalescent plasma successfully treats a severe COVID-19 patient with multi-organ failure.
Biomedical Research and Therapy,
7(10), 4022-4025. https://doi.org/10.15419/bmrat.v7i10.635
Shereen, M., Ullah, H., Khan, S., Bashir, N., Kazmi, A., Saif, K., & Qudus, M. (2020).
COVID-19 around the world and the Chinese strategy to cope with SARS-CoV-2.
Biomedical Research and Therapy,
7(7), 3890-3897. https://doi.org/10.15419/bmrat.v7i7.618
Shereen, M., & Kazmi, A. (2020).
SARS-CoV-2 pandemic: causes and current situation, historical lessons, and strategical therapeutic interventions.
Biomedical Research and Therapy,
7(5), 3807-3812. https://doi.org/10.15419/bmrat.v7i5.608
Submitting articles on COVID-19
Articles on the current outbreak will be added to this collection as soon as they are published. We are also pleased to announce that any COVID-19 paper suitable for publication after peer review will have the fees waived. Our Open Access mission continues to support research moving forward by ensuring there are no barriers to any of our articles.
Please make new submission here.